Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis.

Blum, J

Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. [electronic resource] - Tropical medicine & international health : TM & IH May 2001 - 390-400 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1360-2276

10.1046/j.1365-3156.2001.00710.x doi


Adult
Angola
Central Nervous System Protozoal Infections--chemically induced
Drug Administration Schedule
Female
Humans
Male
Melarsoprol--administration & dosage
Middle Aged
Predictive Value of Tests
Risk Factors
Syndrome
Time Factors
Treatment Outcome
Trypanocidal Agents--administration & dosage
Trypanosomiasis, African--complications